Alkyl Amines Chemicals logo

Alkyl Amines Chemicals share price

NSE: ALKYLAMINEBSE: 506767Chemicals & PetrochemicalsSmall Cap

Alkyl Amines Chemicals Limited · Face value ₹2 · Listed Feb 1981 on BSE, Nov 2007 on NSE
Last close ₹1,653.80up ₹1.90 (0.12%)BSE ₹1,655.50

Share price at the NSE close on 29 Oct 2026. Previous close ₹1,651.90.

29 Oct: open ₹1,650.00, high ₹1,667.20, low ₹1,631.20

52-week range of traded prices to 29 Oct 2026
₹1,212.00Low, 17 Mar 2026₹2,115.00High, 24 Aug 2026
Market cap
₹8,459 Cr628th largest listed
P/E
37.56
P/B
5.52
Dividend yield
0.60%
ROE
15.3%
ROCE
17.6%
Debt to equity
0.00
Volume, NSE
19,16743.9% delivered

Alkyl Amines Chemicals share price chart

Daily closes since Jan 2007, BSE closes Jan 2007 to Nov 2007, adjusted for splits and bonuses

−13.1%over a year · Nifty Microcap 250 +2.5% · Nifty 500 −8.4%

Results20-session average 2,02,221 shares a day, 39.8% delivered

About Alkyl Amines Chemicals

Alkyl Amines Chemicals Limited makes amines (chemicals derived from ammonia), amine derivatives and other specialty chemicals used by the pharmaceutical, agrochemical, water treatment and rubber chemical industries.1 Its registered office is in Navi Mumbai and its corporate office in Mumbai; it manufactures in Maharashtra and Gujarat and sells in India and abroad.1

It has 3 manufacturing sites, at Patalganga and Kurkumbh in Maharashtra and at Dahej in Gujarat, as well as 3 solar plants.12 It reports a single business segment, specialty chemicals, and has no subsidiary.34 At the end of March 2026 it had 697 employees, 682 of them permanent, and a further 975 workers.5

It was incorporated in 1979.6 At the end of March 2026, Yogesh M. Kothari, its chairman and managing director and its promoter, held 57.64% of its shares.789 His son, Suneet Y. Kothari, an executive director, belongs to the promoter group.10

Alkyl Amines Chemicals key points

Results

  • In the year to Mar 2026, total income (revenue from operations plus other income) was ₹1,56,751 lakh against ₹1,60,162 lakh a year earlier, and profit before tax was ₹24,347 lakh against ₹24,864 lakh.11
  • Profit after tax for the year to Mar 2026 was ₹18,000 lakh, down 3% from ₹18,611 lakh a year earlier.12
  • For the year to Mar 2026, the board recommended a dividend of ₹10 per share of face value ₹2, the same as for the year before, subject to shareholders' approval; the company's documents give no outcome.13

Revenue mix

  • Share of turnover by product line14
    Itemyear to Mar 2026
    Aliphatic amines44.55%
    Amine derivatives30.67%
    Specialty chemicals and amines24.78%
  • No single customer accounted for more than 10% of the company's revenue in the year to Mar 2026 or the year before.15

Where revenue comes from

  • In the year to Mar 2026, gross domestic sales (before deductions, as the company presents them) were ₹1,37,670.28 lakh against ₹1,39,147.41 lakh a year earlier, and exports, valued free on board (at the port of shipment), were ₹31,861 lakh against ₹34,309 lakh.16
  • Exports made up 22.66% of turnover in the year to Mar 2026, with customers in 39 countries; in India the company sells in 21 states.17

Research and development

  • The company runs a research and development centre and a technology and projects office in Pune, Maharashtra.18
  • Research and development spending was ₹959.95 lakh in the year to Mar 2026, 0.63% of total turnover.19
  • In the year to Mar 2026, the company commercialised a purification process for a high-grade specialty product and a process that recovers products from a waste stream.20
  • The company stated in its annual report for the year to Mar 2026 that an improved process for a complex specialty product is due to be commercialised in the year to Mar 2027.21

Expansion and capital spending

  • The company stated in its annual report for the year to Mar 2026 that its specialty chemical project at Dahej was under execution, with commissioning expected early in the quarter to Sep 2026; the company's documents give no outcome.22
  • Capital work in progress (plant being built and not yet in use) was ₹13,048.12 lakh at 31 Mar 2026.23

Ammonia supply and imports

  • In its annual report for the year to Mar 2026, the company said a shortage of liquefied natural gas, used to make ammonia, forced it to briefly suspend making methylamines, ethylamines and their derivatives at Patalganga, Kurkumbh and Dahej.24
  • The company said the ammonia supply situation remained uncertain and dynamic but had improved enough for it to restart ammonia-based production gradually, and that products not made from ammonia continued at its sites.25
  • India's Ministry of Finance levied an anti-dumping duty (a tariff on imports priced below fair value) on acetonitrile in June 2025; dumping continued through the quarter to Dec 2025, then imports fell in the quarter to Mar 2026 and the company's acetonitrile market share rose.26
  • The company said its agrochemical and pharmaceutical customers face competition from Chinese manufacturers, and that this has affected its sales to major customers.27

Recent events

  • In its exchange filing of 29 Dec 2025, the company said CRISIL Ratings had reviewed and reaffirmed its credit ratings (its view of the company's ability to repay debt) of AA-/Stable for long-term and A1+ for short-term bank facilities totalling ₹189.38 crore.28
  • On 7 Apr 2025, the Industries Commissionerate approved a grant to the company for setting up its new plant at Dahej, Gujarat.29

Litigation and regulatory matters

  • At the end of March 2026, claims against the company that it does not accept as debt totalled ₹3,684.29 lakh, against ₹3,618.18 lakh a year earlier.30
  • As of its annual report for the year to Mar 2026, the company was disputing customs duty of ₹1,405.22 lakh before the Bombay High Court, against ₹1,297.57 lakh a year earlier, and had deposited ₹250 lakh.313233
  • As of the same report, it was disputing excise duty of ₹1,216.03 lakh, against ₹1,260.77 lakh a year earlier, before the Customs, Excise and Service Tax Appellate Tribunal, where it had deposited ₹21.07 lakh.3133

Results

Standalone, as consolidated accounts are on record for only 4 of the last ten years; ₹ crore.Alkyl Amines Chemicals quarterly results

Revenue growth, 12 months
+5.1%
Net profit growth, 12 months
+20.6%

Quarter to Jun 2026, against the quarter before

Revenue
₹528 Crup 36.47%
Net profit
₹95 Crup 108.57%
Net margin
17.9%

Revenue by quarter

₹415 CrSep 24₹371 CrDec 24₹386 CrMar 25₹406 CrJun 25₹389 CrSep 25₹354 CrDec 25₹387 CrMar 26₹528 CrJun 26
Peak revenue ₹528 Cr, quarter to Jun 2026; lowest ₹354 Cr, quarter to Dec 2025

Net profit by quarter, a loss in red

₹47 CrSep 24₹44 CrDec 24₹46 CrMar 25₹49 CrJun 25₹43 CrSep 25₹42 CrDec 25₹45 CrMar 26₹95 CrJun 26
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue415371386406389354387528
Net profit4744464943424595
Net margin11.4%11.8%11.9%12.2%11.0%11.9%11.7%17.9%
Standalone. The last eight quarters. The latest is shaded.

Business segments

In the year to Mar 2026 the company reports one business segment, Specialty Chemicals, which carries all its revenue.

Valuation

Today, against the company's own history.Alkyl Amines Chemicals PE ratio and valuation

Price to earnings

At or below today's level on 42% of 2,479 trading days over the last 10 years.

LowestHighest
Its median45.97Industry median23.83
Price to book

At or below today's level on 18% of 1,978 trading days since Nov 2018.

LowestHighest
Its median8.65Industry median2.41
Dividend yield

At or below today's level on 59% of 2,462 trading days over the last 10 years.

LowestHighest
Its median0.53%Industry median0.51%

Where the return came from

Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.

OverReturn a yearEarnings growthChange in P/EDividend yield
1 year−23.1%−3.3%−21.3%0.8%
3 years−16.4%−7.7%−10.1%0.7%
5 years−11.0%−9.5%−2.3%0.6%
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add.

Shareholding

Per cent of the company's shares, from the filing for Sep 2026.Alkyl Amines Chemicals shareholding pattern

Shareholding by group

  • Promoters72.04%
  • Foreign institutions3.46%
  • Indian institutions3.26%
  • Individuals and others21.24%
Holder
YOGESH M KOTHARIPromoter57.64%
NIYOKO TRADING AND CONSULTANCY LLPPromoter3.83%
PURJEEKO TRADING & CONSULTANCY LLPPromoter3.81%
NINI YOGESH KOTHARIPromoter2.48%
IKIGAI EMERGING EQUITY FUNDAlternative investment funds1.62%
SYK TRADING AND CONSULTANCY LLPPromoter1.54%
Holders are named in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here and listed fund by fund below.

Since Jun 2026: promoters unchanged, foreign institutions −0.03 pts, Indian institutions +0.15 pts, mutual funds +0.08 pts.

Mutual fund holdings

11 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 4 of the 5 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future.All 11 funds holding Alkyl Amines Chemicals

Added
2
Cut
3
Held unchanged
6
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.

Promoter and insider buying and selling

Trades made since 30 Oct 2025.Alkyl Amines Chemicals insider trading

Bought on the market Sold on the market
  • Promoters and promoter group1 purchase, 0 sales₹1.27 CrNo saleNet₹1.27 Cr
  • Directors and key managers0 purchases, 1 saleNo purchase₹0.98 CrNet−₹0.98 Cr1 off-market move
  • Employees0 purchases, 1 saleNo purchase₹1.12 CrNet−₹1.12 Cr1 off-market move
  • Others0 purchases, 3 salesNo purchase₹1.23 CrNet−₹1.23 Cr7 off-market moves
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.

Alkyl Amines Chemicals competitors and peers

Specialty Chemicals, 130 listed companies, priced on 29 Oct 2026. The table lists the 8 companies closest to Alkyl Amines Chemicals in market cap.Chemical companies

Where the company sits among the companies nearest its size

Return on equity across, P/E up, size is market cap
Company
Sudeep Pharma logoSudeep PharmaSUDEEPPHRM12,76467.5813.33––22.5%20.1%0.13%
Vinati Organics logoVinati OrganicsVINATIORGA10,76724.013.41+5.1%+5.4%15.1%17.3%0.82%
Elantas Beck India logoElantas Beck IndiaELANTAS10,37355.519.40+18.9%+35.3%18.3%18.8%0.06%
Jubilant Ingrevia logoJubilant IngreviaJUBLINGREA9,04525.802.73+15.4%+21.7%11.0%12.0%0.88%
Clean Science and Technology logoClean Science and TechnologyCLEAN7,86733.774.97−0.4%−13.3%15.5%17.1%0.81%
Galaxy Surfactants logoGalaxy SurfactantsGALAXYSURF7,70421.772.81+27.1%+16.1%13.9%16.2%1.01%
Neogen Chemicals logoNeogen ChemicalsNEOGEN6,795191.08–+18.0%+6.0%4.4%5.8%0.04%
Balaji Amines logoBalaji AminesBALAMINES5,99029.223.03+11.1%+34.8%10.7%11.8%0.60%
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.

Dividends

Per share, by the year it was paid for, and the latest payments.Alkyl Amines Chemicals dividend history

Dividend per share, ₹, restated for later splits and bonuses

2Mar 172.8Mar 183.2Mar 198Mar 2010Mar 2110Mar 2210Mar 2310Mar 2410Mar 2510Mar 26
Highest ₹10.00 a share, in 6 years, the latest the year to Mar 2026.
Ex-dateTypePer share
25 Jun 2026Final₹10.00
24 Jun 2025Final₹10.00
25 Jun 2024Final₹10.00
4 Jul 2023Final₹10.00
22 Jul 2022Final₹10.00
12 Jul 2021Final₹6.00
Latest payments, as declared, by ex-date.

Latest announcements

Routine notices left out.Alkyl Amines Chemicals announcements

Alkyl Amines Chemicals share price by year

Each calendar year to 2025.Alkyl Amines Chemicals share price history

YearClose at year endChangeHighest closeLowest close
20251,596.10−9.4%2,398.001,557.80
20241,762.05−30.5%2,701.351,720.75
20232,535.75−4.7%2,750.752,124.20
20222,661.80−25.0%3,759.352,517.65
20213,547.70+131.6%4,622.651,552.20
20201,531.98+253.0%1,646.42433.56
2019434.00+35.1%435.28275.42
2018321.30+20.0%321.30216.52
2017267.80+118.6%267.80122.64
2016122.50−16.2%154.84114.48
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.

Recent sessions

The 9 trading days to 28 Oct 2026, as traded on NSE; the latest is at the top of the page.

DateOpenHighLowCloseAverage priceVolumeDelivery
28 Oct 20261,646.301,683.601,634.701,651.901,654.7838,00145.7%
27 Oct 20261,632.001,675.001,624.101,646.301,652.0851,22155.0%
26 Oct 20261,642.001,666.001,620.101,637.001,639.1635,58340.7%
23 Oct 20261,710.001,710.001,603.201,634.801,639.3351,46646.2%
22 Oct 20261,721.401,737.401,683.901,704.201,707.1134,81434.2%
21 Oct 20261,800.001,800.001,706.001,721.401,738.2244,47344.3%
19 Oct 20261,844.701,844.701,772.101,788.501,802.7030,31750.7%
16 Oct 20261,838.601,868.901,822.001,844.701,847.1022,41543.0%
15 Oct 20261,878.501,889.901,831.201,838.501,860.6529,64251.6%
Prices in ₹ per share as traded, not adjusted.

Price adjustments

What the price chart is corrected for, so it reads as one share held throughout.Stock split history

Ex-dateEventPrice factorWhat happened
11 May 2021Split0.4000Every 2 shares became 5.
8 Sep 2014Split0.5000Each share became 2.
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.

Company details

Chairperson and managing director
Yogesh M. Kothari
At the end of the quarter to Sep 2026
NSE symbol
ALKYLAMINE
BSE code
506767
ISIN
INE150B01039
Industry
Chemicals & Petrochemicals
CIN
L99999MH1979PLC021796
Corporate identity number, the registrar of companies' code for it
Incorporated
1979
Registered office
401-407, Plot No 10, Nirman Vyapar Kendra, Sector 17, Vashi, Navi Mumbai 400703, Maharashtra
Share registrar
MUFG Intime India Pvt. Ltd
Keeps the register of shareholders and handles transfers and dividend payments